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Abstract
Background: The various classes of small noncoding RNAs (sncRNAs) are important regulators of gene expression
across divergent types of organisms. While a rapidly increasing number of sncRNAs has been identified over recent
years, the isolation of sncRNAs of low abundance remains challenging. Virally encoded sncRNAs, particularly those
of RNA viruses, can be expressed at very low levels. This is best illustrated by HIV-1 where virus encoded sncRNAs
represent approximately 0.1-1.0% of all sncRNAs in HIV-1 infected cells or were found to be undetected. Thus, we
applied a novel, sequence targeted enrichment strategy to capture HIV-1 derived sncRNAs in HIV-1 infected
primary CD4+ T-lymphocytes and macrophages that allows a greater than 100-fold enrichment of low abundant
sncRNAs.
Results: Eight hundred and ninety-two individual HIV-1 sncRNAs were cloned and sequenced from nine different
sncRNA libraries derived from five independent experiments. These clones represent up to 90% of all sncRNA
clones in the generated libraries. Two hundred and sixteen HIV-1 sncRNAs were distinguishable as unique clones.
They are spread throughout the HIV-1 genome, however, forming certain clusters, and almost 10% show an
antisense orientation. The length of HIV-1 sncRNAs varies between 16 and 89 nucleotides with an unexpected peak
at 31 to 50 nucleotides, thus, longer than cellular microRNAs or short-interfering RNAs (siRNAs). Exemplary HIV-1
sncRNAs were also generated in cells infected with different primary HIV-1 isolates and can inhibit HIV-1 replication.
Conclusions: HIV-1 infected cells generate virally encoded sncRNAs, which might play a role in the HIV-1 life cycle.
Furthermore, the enormous capacity to enrich low abundance sncRNAs in a sequence specific manner highly
recommends our selection strategy for any type of investigation where origin or target sequences of the sought-
after sncRNAs are known.
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Background
One major posttranscriptional regulatory pathway, RNA
interference (RNAi), is mediated by small noncoding
RNAs (sncRNAs) [1]. Over recent years, the importance
of the diverse classes of sncRNAs has been widely
recognized and their impact on various biological pro-
cesses demonstrated across a broad variety of organisms
[2]. The most intensively studied class of sncRNAs are
the 20-25 nucleotides long microRNAs (miRNAs) which
play a crucial role in posttranscriptional regulation of
gene expression [3].
Despite technological advances sncRNAs of low abun-
dance have remained difficult to identify. To date, the
most frequently employed method to derive sncRNAs is
the generation of cDNA libraries encoding sncRNAs by,
rather rate limiting, cloning and sequencing procedures
[4]. While this technique allows the identification of
sncRNAs of medium to high frequency with notable
success, it remains less effective in defining low
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abundant sncRNAs. Alternate approaches have
employed microarray- and PCR-based technologies to
detect and quantify sncRNAs [4,5]. However, due to the
short length of oligonucleotides used in microarrays and
the target specificity of PCR, these procedures only lend
themselves towards analyses where already known or
predicted sncRNAs need to be detected. More recently,
high-throughput sequencing techniques have been
applied [6-8].
Discovery and screening for viral sncRNAs in infected
cells faces two challenges: Firstly, sequence and length
of these viral sncRNAs are yet unknown excluding
approaches which depend on target specific amplifica-
tion. Secondly, depending on the virus studied, virus-
encoded sncRNAs may be of extremely low abundance.
The first discovery of viral miRNAs was made in
Epstein-Barr virus (EBV)-infected human cell lines [9]
where 4.15% sncRNAs of EBV origin were identified.
The specificity could be enhanced by employing sub-
tractive hybridization which yielded libraries consisting
of ~40% EBV derived sncRNAs [10]. A similar high
abundance of viral sncRNAs was also observed in cells
infected with other DNA viruses [11]. However,
sncRNAs from RNA viruses have thus far proven less
frequent, accounting commonly for < 1% of all sncRNAs
in infected cells [12] (see also Note added in proof).
HIV-1 generates very low abundance [8,11,13] or
undetected [14] sncRNAs. So far, only four sncRNAs
with miRNA-like functionality have been identified in
HIV-1 infected cells and mapped to domains in TAR
[15,16], env [17], nef [18], and U3 [19]. The first pub-
lished report on screening for sncRNAs in HIV-1
infected cells detected only two viral sncRNAs in 1,540
clones from HIV-1 infected HeLa T4+ cells (0.13%). No
functional property could be assigned to these HIV-1
sncRNAs and they were accordingly classified as degra-
dation products by the authors [11]. Another study
screened 600 sncRNA clones derived from HIV-1
infected cells for HIV-1 sncRNAs but found none which
contained a viral sequence [14]. More recently, two
independent surveys performed high-throughput
sequencing of HIV-1 infected cell libraries and detected
0.26% [13] and 1.0% [8] HIV-1 sncRNAs in approxi-
mately 48,000 and 2.5 million screened sncRNAs,
respectively.
As these studies highlight, identification of low abun-
dant sncRNAs, such as HIV-1 encoded sncRNAs,
requires either screening of a large number of sequences
or an optimized selection protocol. Here we report on a
novel selection and enrichment strategy for low abun-
dant sncRNAs. Key to this approach is a highly effective
enrichment by hybridization capture where hybridization
probes covering the entire genome of the organism of
interest - in our case HIV-1 - are included. This
approach is highly successful in detecting low abundant
HIV-1 sncRNAs in cDNA libraries obtained from HIV-1
infected primary human cells. The yield of HIV-1
sncRNAs increased from previously reported 0.1-1.0% to
an average of 78.3% (± 7.6% (SD)) of total sncRNAs in
several independent libraries.
Using this approach, we captured almost 900 HIV-1
sncRNAs, 216 of them distinguishable, in nine sncRNA
libraries. HIV-1 sncRNAs are highly variable in terms of
their lengths, location on the HIV-1 genome, and polar-
ity. Tested sense/antisense hybrids of HIV-1 sncRNAs
inhibit virus replication.
Results
Enrichment and selection of low abundant HIV-1 sncRNAs
by hybridization capture
One aim of our study was to derive an effective selec-
tion strategy for low abundant sncRNAs which would
allow 1) to determine the presence or absence of
sncRNAs in a given setting and 2) to allow the charac-
terization of the full spectrum of sncRNAs generated by
HIV-1 where conflicting reports have been published
which suggested that either no or only extremely low
numbers of HIV-1 sncRNAs are evolved in infected
cells. As outlined in the following procedures, we
achieved this by introducing a specific selection step
which enriched for HIV-1 derived sequences. Figure 1
illustrates the various steps involved in our sncRNA
selection procedure. One step is key for the success of
our procedure as we enriched for HIV-1 encoded
sncRNAs by specifically selecting HIV-1 sncRNAs which
bound to single-stranded HIV-1 DNA in a hybridization
step (Figure 1, Step 5). The HIV-1 ssDNA hybridization
probes used for this purpose were generated from pro-
viral DNA of HIV-1JR-FL by PCR. In total, five probes
covering the entire HIV-1 genome were generated (Fig-
ure 1, Box 1). The primers used to amplify those hybri-
dization probes were biotinylated which allowed us to
couple the derived probes to streptavidin beads. Adap-
tor-ligated cDNA derived in Step 4 was then hybridized
to the HIV-1 ssDNA hybridization probes, followed by a
magnetic bead purification step to eliminate nonhybri-
dized cDNA species (Figure 1, Step 5). The five HIV-1
ssDNA hybridization probes were either used together
(as shown in Figure 1, Step 5) or in separate reactions.
Both approaches proved equally effective. Bead enriched
cDNA was then cloned and sequenced (Figure 1, Step
8), but could also be analyzed by next-generation
sequencing technologies.
We successfully employed this procedure, performing
one round of selection, for two independent cDNA
libraries which yielded 4.8% and 12.9% clones with
sequence homology to HIV-1 (Figure 2, Additional file
1: Table S1), respectively. While the achieved
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Figure 1 Strategy of cDNA library generation with hybridization capture for HIV-1 encoded small noncoding RNAs (sncRNAs). HIV-1
susceptible cells (in our set-up, primary human macrophages or CD4+ T-lymphocytes) are infected with HIV-1 (Step 1). Cellular (black) and HIV-1
encoded (bright green) sncRNAs (< 200 nt) are extracted from HIV-1 infected cells (Step 2). RNA is C-tailed at the 3’-end, adaptor-ligated at the
5’-end (Step 3), and RT-PCR is performed (Step 4). For the preparation of the HIV-1 ssDNA hybridization probes, PCR is performed with
biotinylated primers for 5 overlapping regions of the genome using HIV-1JR-FL plasmid as template. Biotinylated amplicons are attached to
streptavidin beads (Box 1). Sequences homologous to HIV-1 are enriched by incubation of cDNA derived from adaptor-ligated sncRNAs with a
mixture of the 5 different HIV-1 ssDNA hybridization probes (Step 5); alternatively each HIV-1 ssDNA hybridization probe can be used separately.
After hybridization capture, bound amplicons are eluted, amplified, and size selected on a gel (Step 6). The hybridization and size selection steps
can be repeated (Step 7). Amplicons are cloned and sequenced or can be sequenced using next-generation sequencing technologies (Step 8).
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enrichment for HIV-1 sncRNAs was already more than
an order of magnitude higher than frequencies reported
in the previously published studies, we aimed to further
enrich HIV-1 sncRNAs by performing a second round
of hybridization capture. We generated in total seven
sncRNA libraries that underwent two consecutive hybri-
dization selections and were all highly enriched for
HIV-1 sncRNAs yielding on average 78.3% (± 7.6%
(SD)) HIV-1 encoded clones (Figure 2A, Additional file
1: Table S1). These results highlight that our approach
has a striking capacity to enhance the retrieval of low
abundant sncRNAs. In our model system, we achieved a
greater than 100-fold increase in the selection of HIV-1
encoded sncRNA species over average levels reported in
the literature.
To verify that the individual HIV-1 ssDNA hybridi-
zation probes selected specifically HIV-1 sncRNAs of
the respective region, we generated two libraries (H
and J) where HIV-1 ssDNA hybridization probes were
utilized in separate reactions in the two rounds of
selection. We found that 92.8 ± 7.9% (mean ± SD) of
the thereby recovered HIV-1 sncRNAs were specifically
enriched (Additional file 2: Table S2). Hybridization
proved highly specific. Only rare false positive hybridi-
zation was observed. The latter occurred mostly
amongst HIV-1 sncRNAs within the RU5 region (con-
tig 2, Additional file 3: Table S3), the location for a
highly abundant HIV-1 sncRNA contig (Figures 3A
and 4B).
Characterization of HIV-1 small noncoding RNAs
In total, we derived 1,335 clones from nine individual
sncRNA libraries generated from HIV-1 infected pri-
mary cells after one or two rounds of hybridization cap-
ture (A-J, Additional file 1: Table S1). Clones were
defined as valid sncRNA candidates when they 1) con-
tained the C-tail and the 3’ and 5’ adaptor sequences
and 2) were in the size range of > 15 and < 100 nucleo-
tides. Eight hundred and ninety-two of these clones had
a greater than 90% homology to the strain HIV-1JR-FL
used for infection. Of these, 216 clones were distin-
guishable as unique clones by various measures (for
example, derived from different libraries or differed in
length and/or position; Additional file 3: Table S3). It
can be reasoned that identical clones within one library
may indicate sncRNA species which occur at higher
abundance. However, deriving quantitative conclusions
from our type of analysis is difficult as it cannot be
ruled out that preferential amplification of certain clones
occurred during PCR.
We aligned these 216 unique HIV-1 sncRNAs to the
reference strain HIV-1HXB2 (Figure 3A, Supplementary
dataset 1). They had a length of 43 ± 14 nucleotides
(mean ± SD, range: 16-89 nt) (Figure 3B). Based on this
alignment we found that the derived HIV-1 sncRNAs
grouped within 67 different contigs, that is, single or
clusters of overlapping HIV-1 sncRNAs. Forty-five con-
tigs (67.2%) contained 2 to 17 unique sncRNAs that
could represent groups of isosncRNAs similar to the
recently described isomiRs [20]. Thirty-seven contigs
harbored sncRNAs identified in at least two different
libraries highlighting that these sncRNAs were not
formed randomly. The contigs were spread throughout
the HIV-1 genome, and the majority of them consisted
entirely of sense sncRNAs (56 contigs, 84%). Twenty-
one antisense sncRNAs were detected in either antisense
only contigs (6 contigs, 9%) or in mixed sense and anti-
sense contigs (5 contigs, 7%). Of note, sncRNAs with
differential polarity in these mixed contigs have the
potential to form double-stranded sncRNAs. For the 5
mixed sense/antisense contigs the double-stranded over-
lap ranges between 7 and 27 nucleotides (contigs no. 3,
52, 58, 62, and 65, Additional file 3: Table S3).
Due to the unexpected length of HIV-1 sncRNAs,
which is longer than cellular miRNAs, we analyzed sepa-
rately four libraries from two independent experiments
(libraries F-J, Figure 2) where we separated the dehybri-
dized cDNA into two fractions of 50-80 and 80-110
base pairs in length, which after subtracting the lengths
of adaptors and the C-tail leads to lengths of HIV-1
sncRNAs of ≤ 25 and 25-55 bp, respectively, before
Figure 2 Efficiency of hybridization capture to enrich HIV-1
encoded sncRNAs. Comparison of published data using the
currents standard protocols (left) with our novel selection strategy
(right). Standard protocols with no selection led to a yield of 0.1-
1.0% HIV-1 sncRNAs. Numbers above bars indicate the respective
literature references [8,11,13]. Using our novel method, application
of one round of hybridization capture yielded 8.9 ± 5.7% (mean ±
SD) HIV-1 sncRNAs (libraries A and B). Performing two consecutive
rounds of selection (libraries C-J) optimized the yield to 78.3 ± 7.6%
(mean ± SD) HIV-1 sncRNAs.
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subjecting the cDNA to a second round of hybridization
enrichment. With this approach, we wanted to explore
if the target molecule length has an influence on hybri-
dization efficacy. The latter was a reasonable concern as
it was previously suggested that short molecules are dif-
ficult to select by hybridization capture [21]. However,
we could not confirm this suggestion in our setup.
While as expected the separate size selection resulted in
a significant difference of the median size of sncRNAs
(25 nt [interquartile range, IQR: 22-33] and 44 nt [IQR:
33-51] for the 50-80 and 80-110 bp fraction, respec-
tively, p < 0.0001, Wilcoxon rank sum test) (Figure 3C),
the specificity of the hybridization capture for the smal-
ler size sncRNA fraction was only slightly lower than for
the larger size fraction (69.5% vs. 81.3% HIV-1
sncRNAs). One hundred forty-six of 364 (40.1%)
Figure 3 Alignment and characterization of identified sncRNAs. (A) 216 unique sncRNAs from nine libraries (Supplementary dataset 1) were
aligned to the reference strain HIV-1HXB2 and cluster in 67 contigs distributed throughout the whole genome of HIV-1. The coverage of sncRNA
per nucleotide, the single unique clones (black: sense HIV-1 sncRNAs, pink: antisense HIV-1 sncRNAs), and the contig numbers are shown. (B) The
length (nucleotides, nt) distribution of all unique HIV-1 sncRNAs is depicted. Sense sncRNAs are shown in black, antisense sncRNAs are shown in
pink. (C) Probing the influence of target molecule length on hybridization efficacy, libraries F, G, H, and J underwent a second size separation
step before undergoing a second round of hybridization enrichment. Dehybridized cDNA was separated into two fractions of 80-110 bp or 50-
80 bp length and both probed separately for hybridization efficacy. Green full circles denote HIV-1 derived sncRNAs, black open circles denote
non-HIV-1 sncRNAs. Both fractions successfully retrieved sncRNA in the second round hybridization. 20-25 nucleotide long sncRNAs were
retrieved from both fractions and comprised 40.1% of all sncRNAs in the small size fraction and 11.1% in the large size fraction (p < 0.0001, Chi
square test). (D) Pie chart depicting the distribution of different human cellular sncRNAs in all libraries.
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Figure 4 Functional analysis of HIV-1 sncRNAs. (A) CD4+ T-lymphocytes of three healthy donors were infected with the indicated five
different HIV-1 primary isolates and screened for the presence of HIV-1 sncRNAs in 3 contigs (contigs 2, 43, and 58) identified in HIV-1JR-FL
infected cultures. Cell cultures from three HIV-1 negative donors were probed for each virus, and the cultures which scored positive for the
respective HIV-1 sncRNAs are depicted in red squares. (B) Primary macrophages and CD8+ T-cell depleted PBMCs of two healthy donors were
infected with HIV-1JR-FL and HIV-1 sncRNA contig 2 (green) and contig 58 (orange) which were quantified by qPCR 14 (macrophages) and 6
(CD8+ T-cell depleted PBMC) days post infection. Amplification was unsuccessful in non-infected cells (data not depicted). As controls, the
cellular miRNAs hsa-miR-21 (white and light grey for non-infected cells) and hsa-miR-223 (black and dark grey for non-infected cells) were
quantified. < d.l., below detection limit of 1 RNA copy/103 cells. (C) Predicted secondary structures of sncRNALTR6, hybrids of sense and antisense
orientated clones from contig 58, namely sncRNAenv183, sncRNAenv184 and sncRNAenv185, and the positive control siRNA-M184 pol [24]
(Additional file 3: Table S3) are depicted. (D) Inhibition of HIV-1 replication in primary macrophages by HIV-1 sncRNAs. Macrophages were
infected with HIV-1JR-FL seven days before transfection with sncRNAs. On day 0 cells were transfected with 50 nM of the indicated sncRNA
(sncRNALTR6 (green), sncRNAenv183&185 (orange), sncRNAenv184&185 (red)) and viral replication was monitored by p24 ELISA on days 0, 5, 9, and
13 post transfection. Mock transfected (black), scrambled sncRNA (blue) and siRNA nonsense (grey) were used as negative control, and siRNA-
M184 pol [20] (open circles) as positive control. (E) Western blot of primary macrophage lysates probed with anti-MxA antibody or anti-b-actin
antibody as control. Primary macrophages were transfected with siRNA nonsense, sncRNAenv183&185, and sncRNAenv184&185 or treated with
interferon-aA/D (positive control). The negative control comprised of untreated and untransfected macrophages.
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sncRNA clones showed a length of 20-25 nucleotides in
the smaller size fraction as compared to 41 of 386
(11.1%) in the larger size fraction (p < 0.0001, Chi
square test). We can safely conclude that sncRNA
clones of smaller size can also be efficiently derived
using our hybridization capture. Thus, the observed
length distribution of the HIV-1 sncRNAs reflects the
repertoire of these small RNAs in HIV-1 infected pri-
mary macrophages and CD4+ T-lymphocytes.
Our selection procedure was highly successful in both
selecting a high number of HIV-1 sncRNAs and also in
defining new HIV-1 sncRNA species. Of the identified
216 unique HIV-1 sncRNAs, eight correspond to pre-
viously described HIV-1 miRNAs: Six sncRNAs corre-
spond to hiv1-miR-N367 [18] within nef, one to hiv1-
miR-TAR-3p [16], and one to hiv1-miR-H1 [19]. Of par-
ticular note, while not identical in sequence and length,
approximately 70% of our HIV-1 sncRNAs overlap with
the 125 HIV-1 sncRNAs detected by pyrosequencing
[13]. We further compared our 11 contigs consisting of
antisense or sense-plus-antisense HIV-1 sncRNAs with
the eight peaks within the HIV-1 antisense-derived
sncRNAs very recently published by Schopman and col-
leagues [8]. Remarkably, three partial overlaps could be
detected, all located at the 3’ end (contigs 62, 65, and
67, Additional file 3: Table S3; sequences of the eight
peaks were kindly provided by Nick C.T. Schopman).
Although our selection strategy for HIV-1 encoded
sncRNAs is highly effective, we still retrieved approxi-
mately 30% of sncRNAs which were not of HIV-1, but
mostly of human origin. Other clones contained plas-
mid-derived, bacterial or unknown sequences, i.e.
sequences without a match in the GenBank database.
The majority of those human sequences (86%) could be
assigned to various classes of human cellular sncRNAs,
namely, miRNAs, small nucleolar RNAs and transfer
RNAs (Figure 3D). As expected, tRNALys was frequently
found since this tRNA functions as primer for the initia-
tion of reverse transcription of the HIV-1 RNA. Differ-
ent cellular miRNAs have been captured; some of them
show a high homology to HIV-1 and might play a role
in the HIV-1 life cycle (Additional file 4: Table S4). One
miRNA, hsa-miR223, has been previously described to
inhibit HIV-1 replication [22].
HIV-1 sncRNA contigs identify regions for sncRNA
generation across different HIV-1 primary virus isolates
While we were successful in demonstrating that
sncRNAs are generated in HIV-1 infected cells, our ana-
lysis was based on the virus isolate JR-FL. We thus
sought to explore whether the identified sncRNAs are
specific for this particular virus or are ubiquitously gen-
erated in HIV-1 infection. As proof-of-principle, we
investigated the presence of three sncRNA contigs
(contig 2, located in the conserved LTR region, and con-
tigs 43 and 58 both located in env, Additional file 3:
Table S3) in CD8+ T-cell depleted PBMC from HIV-1
uninfected donors infected with five unrelated patient-
derived primary virus isolates, which were obtained dur-
ing acute HIV-1 infection [23]. Isolates were chosen
based on the patient-specific sequences of the env gene
(Philip Rieder, Beda Joos, unpublished data) to assure
annealing of the specific sncRNA primers. By specifically
tailored RT-PCR, all three HIV-1 sncRNA contigs were
detected in most of the infected cultures (Figure 4A),
indicating that these sncRNAs are not specific for an
individual virus strain, nor produced randomly as they
emerge upon infection with genetically divergent HIV-1
strains. Example amplicons of each contig were con-
firmed by sequencing (data not shown).
Specific HIV-1 sncRNAs can inhibit virus replication
Considering the large number of HIV-1 sncRNAs we
isolated and their variable length and orientation, it
remains prudent to explore whether the various sncRNA
species identified have functional properties. Functional
screening of all 67 HIV-1 specific contigs was beyond
the scope of the current analysis. Here we focused on a
proof-of-principle analysis on contigs 2 and 58. These
contigs were chosen based on their secondary structures
which resemble precursor miRNA-like (contig 2) and
siRNA-like features (contig 58). Of note, contig 58 con-
tains sense and antisense sncRNAs. We thus chose two
individual sense/antisense pairs from this contig which
may form hybrids and potentially act like siRNAs (Fig-
ure 4C). The sense sncRNA is 27 nucleotides long, the
antisense sncRNAs 36 and 32 nucleotides, respectively,
thus, longer than cellular miRNAs or commonly used
siRNAs. However, the region of double-stranded RNA is
23 and 21 base pairs long, respectively, which is within
the expected range of miRNAs. To explore if these
sncRNAs have any functional impact on HIV-1 replica-
tion, primary macrophages infected with HIV-1JR-FL
were transfected with HIV-1 sncRNAs. While virus
replication continued in mock, control sncRNA, and
control siRNA cell cultures, HIV-1 production was
potently inhibited both by the two contig 58 hybrids
and the positive control siRNA-M184pol (Figure 4D).
Both inhibited virus replication, probably using the RNA
interference pathway, up to 90% compared to nonsense
siRNA. To rule out that these double-stranded RNA
molecules induce a non-specific interferon response, we
monitored the levels of the myxovirus-resistance protein
A (MxA) which is potently upregulated upon dsRNA
exposure in an interferon dependent pathway [25].
None of the investigated sncRNA hybrids induced an
interferon response in HIV-1JR-FL-infected macrophages
(Figure 4E), further supporting the notion that sequence
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specific functions of these HIV-1 sncRNAs are responsi-
ble for the HIV-1 inhibitory activity. In contrast, the sin-
gle-stranded, hairpin forming sncRNALTR6 had no effect
on virus replication in primary macrophages in the
probed setting (Figure 4D). This preliminary analysis
does not allow us to define the latter as mere degrada-
tion product because we cannot rule out functional
properties of this sncRNA, for instance, during earlier
steps of virus replication.
While the transfection experiments allowed us to ver-
ify the effect of the probed sncRNAs on HIV-1 infec-
tion, quantification of natural occurring sncRNA levels
in unmodified cells is required to define if and at what
levels these RNA molecules can be found in infected
cells. To obtain a first insight on the physiological levels
of HIV-1 specific sncRNAs, we quantified HIV-1
sncRNA contigs 2 (the most abundant of the HIV-1
sncRNA contigs we identified) and 58 in HIV-1JF-RL
infected primary macrophages and CD8+ T-cell depleted
PBMCs from two donors. We detected HIV-1 sncRNA
contig 2 in both macrophages and CD8+ T-cell depleted
PBMC at levels (713-4,615 RNA copies/1,000 cells; Fig-
ure 4B) comparable to low abundant cellular miRNAs
[22,26]. As reference, the highly abundant cellular miR-
NAs hsa-miR-21 and hsa-miR-223 were quantified in
parallel in these samples (Figure 4B). As expected, levels
of HIV-1 sncRNA contig 58 were markedly lower than
those of HIV-1 sncRNA contig 2 in both macrophages
and CD8+ T-cell depleted PBMC (< 1-172 RNA copies/
1,000 cells). Of note, since it is likely that only a fraction
of the cells are infected at the time of HIV-1 sncRNA
quantification, the absolute copy number of HIV-1
sncRNAs may be higher in infected cells. Furthermore,
it must be considered that the copy numbers of these
contigs could potentially be underestimated, since it was
not feasible to generate primers and probes similarly
covering all members of the contigs. The 17 HIV-1
sncRNAs of contig 2 do not have a common overlap;
thus, the chosen primer can hybridize to the majority of
these HIV-1 sncRNAs, but not to all (Additional file 3:
Table S3). For contig 58, the antisense but not the sense
HIV-1 sncRNAs were quantified.
Discussion
Here, we report on a novel, highly efficient selection
method for sncRNAs of low abundance. Detection of
low abundance sncRNAs has proven technically very
challenging which may lead to an underestimation or
lack of evidence for low abundant sncRNAs. HIV-1
encoded sncRNAs were detected at very low frequencies
of 0.1-1.0% in previous studies [8,11,13], or were unde-
tected [14]. Our novel strategy relies on the introduction
of a crucial selection step for sncRNAs homologous to
HIV-1. We achieved this by adding a hybridization
capture step into an improved cloning protocol for iden-
tifying sncRNAs. The hybridization capture was per-
formed with HIV-1 ssDNA hybridization probes,
covering the whole HIV-1 genome, that were attached
to streptavidin beads. Applying two rounds of hybridiza-
tion capture enabled us to enrich the frequencies of
selected low abundant HIV-1 sncRNAs more than 100-
fold over what has been reported [8,11,13]. Importantly,
more than 70% of all obtained sncRNAs were of viral
origin. This is a particular advantage of our strategy.
While high-throughput sequencing techniques certainly
have the capacity to overcome the limitations in identi-
fying low abundant sncRNAs, it must still be considered
that more than 99% of sequenced sncRNAs retrieved by
random sequencing will not be of interest and very low
abundant sncRNAs might still be missed. Our approach
allows for sequence specific selection with high sensitiv-
ity. This is particularly highlighted by the fact that we
succeeded in detecting antisense HIV-1 sncRNAs
despite the fact that HIV-1 antisense transcripts are
described to be generated only at extremely low rates
[27-30].
Separate sncRNA libraries derived from infected pri-
mary cells were generated, in which 216 unique HIV-1
sncRNAs with a mean length of 43 nucleotides were
identified. Although, only 8% of the clones were of
lengths described for genuine miRNAs or siRNAs, it has
to be considered that longer HIV-1 sncRNAs still may
have regulatory functions as recently reported [31,32].
For instance, it is conceivable that longer HIV-1
sncRNAs might play a role in starting the transcription
process or during transcription as shown for other
sncRNAs > 25 nt [33]. Another possibility is that those
longer HIV-1 sncRNAs represent precursor molecules
of miRNAs, although precursor miRNA-like structures
were predicted only for few of them. It has been postu-
lated that short molecules are less likely to be selected
by hybridization capture [21]. However, as we show
here sncRNAs of lower length can also be efficiently
enriched by extracting shorter RNA molecules during
size selection steps. While numerous classes of longer
sncRNAs have been described in the literature, there is
currently no consensus on the understanding by which
processes these RNAs species are generated, and it is
assumed that they have a very broad spectrum of func-
tions [33,34]. The fact that we identified longer
sncRNAs of viral origin at high frequency highlights
that these RNA species warrant further investigation.
Amongst all the different types of sncRNAs identified
in our screen, the capture of antisense HIV-1 sncRNAs
was most surprising to us. Whether or not antisense
HIV-1 RNAs are generated has been highly debated in
the past, and few reports on HIV-1 antisense RNAs can
be found in the literature [27-30]. It has been reasoned
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that the generation of antisense HIV-1 sncRNA might
indeed be possible and occurs via the HIV-1 promoter
in the 3’LTR [29] or via cellular promoters downstream
of the integration site [35].
Many questions regarding the generation of viral
sncRNAs during the HIV-1 life cycle and their function
can and need to be addressed based on our initial obser-
vations and findings. Most importantly the high number
of sncRNAs identified raises the possibility that HIV-1
RNA degradation products were selected. Indeed this
cannot be ruled out entirely and functional analysis of
all sncRNAs is certainly warranted. However, it is
important to note that our procedure excludes the selec-
tion of degradation products generated by the classical
pathways of RNA degradation which generate fragments
lacking the 3’- and 5’-end modifications necessary for C-
tailing and adaptor ligation [36]. Another argument
against the possibility of enriching mainly degradation
products is our observation that 86% of the cellular
RNAs captured by our hybridization technique belonged
to different classes of cellular sncRNAs, only 9% were
classified as mRNA, thus, could potentially be degrada-
tion products. Nevertheless, even if some of the discov-
ered HIV-1 sncRNAs are degradation products, it is not
excluded that they could still play a role in the replica-
tion cycle of HIV-1.
The focus of our study was the enrichment and dis-
covery of HIV-1 encoded, low abundant sncRNAs; how-
ever, numerous cellular miRNAs hybridizing specifically
to HIV-1 were also identified using our hybridization
capture that might be of importance for HIV-1 replica-
tion. One of them, hsa-miR-223, has been identified as
an HIV-1 inhibitory miRNA [22]. This and other HIV-1
inhibitory miRNAs are predominantly expressed in rest-
ing CD4+ T-lymphocytes [22] and have been shown to
be downregulated in monocyte-derived macrophages
[37]. Thus, it is not surprising that we captured hsa-
miR-223 once only in our set-up that screened activated
CD4+ T- lymphocytes and monocyte-derived
macrophages.
Using the virus strain JR-FL, we retrieved a vast num-
ber of HIV-1 sncRNAs. Of particular interest for us was
to define whether these sncRNAs were specific for HIV-
1JR-FL only or were ubiquitously generated in HIV-1
infection. As proof-of-principle we investigated this
question for three contigs. Notably we found that
sncRNAs of all three contigs were generated in cells
infected with unrelated HIV-1 primary virus isolates,
thus, confirming that the generation of these RNA spe-
cies is not virus strain dependent.
Many potential functional properties of HIV-1 specific
sncRNAs can be envisioned with both infection enhan-
cing or reducing capacity. Here we report on functional
assessment of sncRNA candidates from two of the 67
identified contigs. The hybridizing sense and antisense
HIV-1 sncRNAs of contig 58 displayed a siRNA-like
HIV-1 inhibition pattern in primary macrophages. As
we demonstrate here, antisense sncRNAs appear to be
generated during HIV-1 infection, and thus, might have
the potential to downregulate HIV-1 production. This
obviously raises a number of questions: Why would
HIV-1 give raise to such negative regulatory RNAs? If
they act in vivo, would HIV-1 not rapidly escape and
induce countermeasures? Or are these negative regula-
tors necessary for a balanced virus production (for
example, ascertaining appropriate generation of struc-
tural proteins) or maybe in inducing latency? Now that
our novel sncRNA isolation procedure provides the
means to enrich and select these types of HIV-1
sncRNAs with high efficacy, these functional analysis
can be feasible.
Conclusions
In summary, using hybridization capture for the detec-
tion of novel sncRNAs of low abundance is a highly sen-
sitive approach. This is particularly highlighted by our
efficient enrichment of low abundant sncRNAs. More
than 70% of sncRNAs we identified in our HIV-1 tar-
geted screen were indeed derived from HIV-1 RNA
demonstrating a high specificity of this enrichment by
hybridization capture and showing that small RNAs are
generated in HIV-1 infected primary macrophages and
CD4+ T-lymphocytes. HIV-1 encoded sncRNAs vary in
length and in their locations on the viral genome, and
they have the potential to play roles in HIV-1
replication.
Methods
Viruses
Primary HIV-1 isolates [23] were derived from patients’
peripheral blood mononuclear cells (PBMC) by co-cul-
turing patient CD4+ T-lymphocytes with stimulated,
CD8+ T-cell depleted PBMC as previously described
[38]. Patients were enrolled in the Zurich primary HIV
infection (ZPHI) study http://clinicaltrials.gov:
NCT00537966, and written informed consent was
obtained from all participants. Viral replication was, for
all experiments, assessed from culture supernatants by
p24 ELISA (adapted from [39]). TCID50 of primary iso-
lates and CD8+ T-cell depleted PBMC grown HIV-1JR-FL
virus stocks was estimated as described [40].
Cells and infection
PBMC from healthy donors were isolated, CD8+ T-cell
depleted, and CD4+ T-lymphocytes were stimulated and
cultured as described previously [40]. Cells were infected
with HIV-1JR-FL (MOI = 0.01), harvested 7 days post
infection and lysed using QIAzol lysis reagent (Qiagen).
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For the generation of macrophages, primary human
monocytes were isolated from CD8+ T-cell depleted
PBMC using positive selection with anti-CD14-coated
magnetic beads (Miltenyi Biotech). Monocytes (3 × 106
cells per T25 flask) matured to macrophages in the pre-
sence of 0.02 μg/ml human M-CSF (macrophage colony
stimulating factor, PeproTech). Macrophages were
maintained in RPMI-1640 supplemented with 10% FCS,
1% penicillin/streptomycin, 5% MCM (macrophage con-
ditioned medium, sterile-filtered), 5% human serum, and
0.02 μg/ml M-CSF (the latter three ingredients were
added only during the first 6-8 days). After 14 days of
maturation, macrophages were infected with HIV-1JR-FL
(MOI = 0.01). After 14 days, cells were harvested and
lysed using QIAzol lysis reagent (Qiagen).
Isolation of the low molecular weight RNA fraction
Lysed cells were homogenized with QIAshredder (Qia-
gen), and the extraction of small RNA (< 200 nt) was
performed using miRNeasy Mini Kit (Qiagen) according
to the manufacturers’ instructions. RNA was eluted in
40 μl RNase-free water.
Adaptor addition and cDNA synthesis
An aliquot (15 μl) of the low molecular weight fraction
of extracted RNA was C-tailed for 15 min at 37°C using
7.5 units E.coli Poly(A) Polymerase (New England Bio-
labs) and 0.75 mM CTP (Connectorate). The synthesis
of C-tails was blocked by addition of 0.5 mM Cordyce-
pin (Sigma-Aldrich) and 2.5 units E.coli Poly(A) Poly-
merase, and incubation for 15 minutes at 37°C. At the
same time, C-tailed RNA was treated with 15 U DNase
(Roche). Afterwards, precipitation was performed by
adding 1 volume isopropanol, 0.2 M sodium acetate,
and 4 μl precipitation carrier Dr. Gentle (Takara) and
centrifuged for 30 min at 16°C and 16,000 g. The pellet
was washed with 80% ethanol and eluted in 20 μl H2O.
Subsequently, the 5’-end was ligated to an 2’ O-methy-
lated RNA adaptor 5’-AUCGGAACAUCCAGA-
CAUAACA-3’ using 40 U T4 RNA ligase (New England
Biolabs), 4 μM adaptor RNA, and 60 U RNaseOut
(Intvitrogen) (15 min at 37°C and over night at 16°C).
This was followed by precipitation as described above
and elution in 10 μl H2O. cDNA was generated using
M-MuLV Reverse Transcriptase (Finnzymes) and the 3’
linker primer mf331 5’-ACCAGAGTGCGAGTAGGAA-
GATTGGGGGGGGG-3’ partly complementary to the
C-tail of the RNA. Briefly, RNA and 5 μM primer were
denaturated for 5 min at 95°C followed by incubation
on ice for at least 2 min. The enzyme-buffer-dNTP (400
U M-MuLV Reverse Transcriptase, 2.5 mM dNTP) mix-
ture was added, and the reaction was incubated for 60
minutes at 37°C. Amplification of 2 μl cDNA was exe-
cuted with JumpStart Taq ReadyMix (Sigma-Aldrich)
for 15 cycles using 1 μM 5’ adaptor primer mf311 5’-
ATCGGAACATCCAGACATAACA-3’ and 1.5 mM
MgCl2 (95°C-5’; 15 × (95°C-5″; 52°C-5″; 72°C-40″)).
A second round of PCR with 25 cycles was performed
using 1 μl of a 1:10 dilution of the first PCR product.
Again JumpStart Taq ReadyMix (Sigma-Aldrich) supple-
mented with 1.5 mM MgCl2 and 1 μM of each 5’ and 3’
adaptor primers mf311 and mf315 5’-ACCAGAGTGC-
GAGTAGGAAGATT-3’ was used (95°C-2’; 25 × (95°C-
5″; 52°C-5″; 72°C-20″)). Amplicons were precipitated
with isopropanol and dissolved in TENT5/200 (10 mM
Tris-HCl, 5 mM EDTA, 0.2 M NaCl, 0.1% Triton).
Generation of HIV-1 DNA/streptavidin beads for selection
of HIV-1 sncRNAs
The HIV-1JR-FL plasmid [41] was used as template and
amplified with HIV-1 specific biotinylated primers,
using the HotStartTaq Master Mix Kit (Qiagen) supple-
mented with 1.5 mM MgCl2 (95°C 15’; 40 × (95°C 10″-
57°C 10″-72°C 4’); 72°C 7’). Five amplicons were gener-
ated using the following primers that are biotinylated at
the 5’-end: 1) TAR to gag (position according to HIV-
1HXB2 (GenBank accession number K03455): 455-1,658)
with the primers mf271 5’-GGTCTCTCTGGTTAGAC-
CAGATTTGA-3’ and sk39 5’-
TTTGGTCCTTGTCTTATGTCCAGAATGC-3’, 2) gag
to pol (1,273-4,837) with mf219 5’-AAGGCTTT-
CAGCCCAGAAGTAATACCCATGTT-3’ and mf255
5’-ATGTCTACTATTCTTTCCCCTGCA-3’, 3) pol to
env (4,758-6,741) with mf254 5’-CAAATGGCAGTATT-
CATCCACAA-3’ and mf237 5’-ATTCTTCCT-
GATCCCCTTCACTCTCAT-3’, 4) env (5,956-8,421)
with mf1 5’-CTTAGGCATCTCCTATGGCAGGAA-3’
and mf2 5’-TTCCTTCGGGCCTGTCGGGTCCC-3’,
and 5) splice acceptor 7 (sA7) to the 3’LTR (8,317-
9,700) with mf214 5’-TTTTTGCTGTACTTTCTA-
TAGTGAATAGAGTTA-3’ and cr2 5’-TGAC-
TAAAAGGGTCTGAGGGATCTCTAGTTACCAG-3’.
All primers were used in a final concentration of 1 μM.
The PCR products were purified (Qiaquick, Qiagen) and
eluted in 10 mM Tris-HCl (pH 8.5).
Biotinylated DNA was attached to streptavidin beads
(Roche). Either 400 ng of biotinylated DNA from each
PCR were used separately, or in combination (5 × 400
ng) for preparation of the beads. Briefly, 25 μg beads
were washed with TENT100 buffer (10 mM Tris-HCl, 1
mM EDTA, 100 mM NaCl, pH 7.5, 0.1% Triton), and
resuspended in 75 μl 2 × TENT100. Denaturated ampli-
cons (5’, 95°C) were added to the beads, and the volume
was adjusted to 150 μl with H2O. DNA was immobilized
by 30 minutes incubation with the beads at 37°C. Strep-
tavidin-biotinylated, single-stranded DNA complexes
were achieved by heating to 90°C for 1 minute. The
attachement-dehybridization procedure was repeated
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once. Streptavidin-biotinylated-ssDNA complexes were
washed 3 times with TENT1000 (10 mM Tris-HCl, 1
mM EDTA, 1 M NaCl, pH 7.5, 0.1% Triton) and 3
times with TENT100. They were stored in TENT100 at 4°
C.
Selection of HIV-1 sncRNAs
For the hybridization of amplified HIV-1 sncRNAs to
the Streptavidin-biotinylated-ssDNA complexes, 10 μl of
these beads (> 1010 molecules of each HIV-1 ssDNA
hybridization probe) were added to the amplified HIV-1
sncRNAs and incubated for 3 minutes at 95°C followed
by a cool down to 50°C over night on a head to tail
wheel. Beads were washed 4 times with pre-warmed (50°
C) TENT5/200 buffer. Annealed amplified HIV-1
sncRNAs were eluted from the beads by adding 15 μl
Tris-HCl buffer (10 mM Tris-HCl, pH 8.5) and heating
for 5 minutes at 95°C. Beads and eluted sncRNA were
separated by magnetic separation. HIV-1 sncRNAs were
amplified using JumpStart Taq ReadyMix (Sigma) sup-
plemented with 1.5 mM MgCl2 and 1 μM of each adap-
tor-specific primers mf311 and mf315 (95°C-2’; 30 ×
(95°C-5″; 52°C-5″; 72°C-30″)). Amplicons were size-
selected using a 3% MetaPhor agarose gel. DNA with a
length of 50-110 bp was extracted from gel using GenE-
lute Agarose Spin Columns (Sigma). When two selec-
tion steps were performed, eluate was precipitated with
isopropanol and the hybridization and size selection
steps were repeated. Eluates were precipitated with iso-
propanol and eluted in 15 ul H2O.
Cloning and sequencing of HIV-1 sncRNAs
Amplified and selected HIV-1 sncRNAs were ligated
into the vector pDrive using the QIAGEN PCR Cloning
kit (Qiagen). Single clones were sequenced in one direc-
tion with the primer T7 using BigDye chain terminator
chemistry and the automated sequencer ABI 3100
(Applied Biosystems).
Sequences were controlled for the presence of both
adaptor sequences, which were subsequently deleted to
obtain the sncRNA sequence. This analysis was per-
formed using the software BioEdit [42]. All sncRNA
sequences were aligned to the reference strains HIV-
1HXB2 and HIV-1JR-FL using the software DNAstar
(DNA-star Madison). Sequences with > 90% homology
to the reference strain HIV-1JR-FL were considered HIV-
1 specific. FASTA [43] was chosen for further nucleo-
tide similarity searches. Classification of small RNA
sequences was based on sequence analysis using the
GenBank database http://www.ncbi.nlm.nih.gov/gen-
bank/, the miRNA registry database http://www.mirbase.
org/, and the human tRNA database http://gtrnadb.ucsc.
edu/. Secondary structures of selected HIV-1 sncRNA
were predicted with RNAstructure 5.2 [44]. SncRNA
sequences smaller than 16 nucleotides were not
included in our analysis.
Statistical analyses
Statistical analyses were performed using GraphPad
Prism5.0 software. The two-tailed Chi square test and
the Wilcoxon rank sum test were used for binary and
cardinal data, respectively. p < 0.05 was considered sta-
tistically significant.
Transfection of primary macrophages with HIV-1 sncRNAs
Maturated macrophages were generated and infected
with HIV-1JR-FL as described above. Seven days after
infection cells were transfected with HIV-1 sncRNAs
using jetPRIME transfection reagent (Polyplus-Transfec-
tion). Briefly, medium was replaced by Opti-MEM® I
Reduced Serum Media (Invitrogen) and the transfection
mix was added to the cells according to the manufac-
turer’s instructions. After four hours, 10% FCS (Invitro-
gen) was added. The next day the transfection medium
was replaced by RPMI-1640 supplemented with 10%
FCS and 1% penicillin/streptomycin. The following oli-
gonucleotides were used for sncRNA transfection:
sncRNALTR6; sncRNAenv183; sncRNAenv184;
sncRNAenv185 (Supplementary dataset 1). Control
siRNA labelled with AlexaFluor488 (AllStars negative
controls, Qiagen), here named as nonsense siRNA, was
used as control for the transfection efficiency and nega-
tive control for virus inhibition, whereas siRNA-M184pol
was chosen as positive control as previously described
[24]. Western blot analysis for detection of the inter-
feron type I inducible MxA protein was carried out as
previously described using a mouse monoclonal anti-
body directed against MxA [45].
Detection of HIV-1 sncRNAs in cells infected with primary
HIV-1 isolates
HIV-1 sncRNAs detected in most or all of the libraries
were screened in terms of their presence in primary
cells infected with primary HIV-1 isolates. Infection of
CD8+ T-cell depleted PBMC, RNA isolation, C-tailing,
and reverse transcription were performed as described
above. HIV-1 sncRNAs were amplified, using 1 uM of
primer mf315, 1 uM of respective HIV-1 sncRNA-speci-
fic primer (mf382 5’- ATAAAGCTTGCCTTGAGTG-3’,
mf178 5’- ATGGTAGAACAGATGCATGAGGATA-
TAAT-3’, CA-179 5’- CGTTCACTAATCGTCCG-
GATCTGTC-3’) and JumpStart Taq DNA Polymerase
(Sigma). PCR was performed as follows: 95°C-2’; 50 ×
(94°C-10″; 55°C-10″; 72°C-40″). Amplicons were loaded
on 3% MetaPhor agarose gel and separated by electro-
phoresis mobility.
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Quantification of HIV-1 sncRNAs in HIV-1 infected cells
In order to quantify mi/sncRNA in macrophages and
CD8+ T-cell depleted PBMC, the small RNA fraction
was extracted from cell lysate, C-tailed, reverse tran-
scripted, and amplified as described above. Mi/sncRNA
were amplified by using 1 μM of the adaptor primer
mf315 and 1 μM of the corresponding mi/sncRNA spe-
cific primer (hsa-miR-21 5’-TAGCTTATCAGACT-
GATGTTGA-3’, hsa-miR-223 5’-
TGTCAGTTTGTCAAATACCC-3’, mf382 5’-
ATAAAGCTTGCCTTGAGTG-3’, VV153 5’-
CGTTCACTAATCGTCCGGAT-3’). For quantification
via qPCR, EvaGreen™ Dye (Biotium) was used for cellu-
lar miRNAs and 0.3 and 0.2 μM of LNA probes CA20tq
5’-tgTgTgcCcGt-3’ and VV154 5’-TGTctctgtctCT-3’,
respectively, were used for HIV-1 derived sncRNA, LNA
bases are indicated as lower case letters.
Note added in proof
After the submission of this paper, two publications
have appeared which show that RNA viruses can effi-
ciently and physiologically express miRNAs. Work by
Kincaid et al. reported that bovine leukemia virus (BLV)
abundantly expresses a physiological cluster of viral
miRNAs [46]. A separate report by Klase et al. showed
that HIV-1 can express a cellular miRNA inserted into
its viral genome without loss of replication competence
[47].
Additional material
Additional file 1: Table S1. Frequencies of all sncRNA clones containing
the C-tail and both 3’ and 5’ adaptors in each library. Given are absolute
numbers of HIV-1 sncRNAs, their percentages, and total of sequenced
sncRNA clones.
Additional file 2: Table S2. SncRNA libraries generated with separate
HIV-1 ssDNA hybridization probes.
Additional file 3: Table S3. Characteristics of unique HIV-1 sncRNAs.
Additional file 4: Table S4. Captured cellular miRNAs.
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